Tom C. Karagiannis

BakerIDI Heart and Diabetes Institute, The Alfred Medical Research and Education Precinct

Affiliated withThe Alfred Medical Research and Education Precinct University of Melbourne The University of Melbourne

Research Area

Biography

Tom C. Karagiannis has not added Biography.
If you are Tom C. Karagiannis and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 4	Year
Publication title Cited by 23	2010
Publication title Cited by 7	2010
Publication title Cited by 7	2010
Publication title Cited by 223	2011

Other Publications

Article	Year
Epigenetic changes activate widespread signals in response to double-strand breaks. Cancer biology & therapy\| PubMed ID: 15136760	2004
Plasmid DNA breakage by decay of DNA-associated Auger electron emitters: approaches to analysis of experimental data. Radiation research\| PubMed ID: 15222798	2004
siRNAs: mechanism of RNA interference, in vivo and potential clinical applications. Cancer biology & therapy\| PubMed ID: 15539939	2004
Radio- and chemo-sensitization of human erythroleukemic K562 cells by the histone deacetylase inhibitor Trichostatin A. Hellenic journal of nuclear medicine\| PubMed ID: 15841297	2004
RNA interference and potential therapeutic applications of short interfering RNAs. Cancer gene therapy\| PubMed ID: 15891770	2005
The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X. Cancer biology & therapy\| PubMed ID: 16082178	2005
The paradox of histone deacetylase inhibitor-mediated modulation of cellular responses to radiation. Cell cycle (Georgetown, Tex.)\| PubMed ID: 16418577	2006
DNA targeted UVA photosensitization: characterization of an extremely photopotent iodinated minor groove binding DNA ligand. Journal of photochemistry and photobiology. B, Biology\| PubMed ID: 16488619	2006
Radioimmunotherapy: Principles, current trends and future directions. Hellenic journal of nuclear medicine\| PubMed ID: 16868640	2004
Receptor-mediated DNA-targeted photoimmunotherapy. Cancer research\| PubMed ID: 17079478	2006
Comparison of different classes of radionuclides for potential use in radioimmunotherapy. Hellenic journal of nuclear medicine\| PubMed ID: 17684582	2007
Clinical potential of histone deacetylase inhibitors as stand alone therapeutics and in combination with other chemotherapeutics or radiotherapy for cancer. Epigenetics : official journal of the DNA Methylation Society\| PubMed ID: 17965606	2006
The epigenetic modifier, valproic acid, enhances radiation sensitivity. Epigenetics : official journal of the DNA Methylation Society\| PubMed ID: 17965607	2006
Antibody-based cancer treatment with ultra-short range Auger electron-emitting radionuclides: dual receptor and DNA targeting strategies. Hellenic journal of nuclear medicine\| PubMed ID: 18084655	2007
Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments. Cell cycle (Georgetown, Tex.)\| PubMed ID: 18239454	2008
gamma-radiation-induced gammaH2AX formation occurs preferentially in actively transcribing euchromatic loci. Cellular and molecular life sciences : CMLS\| PubMed ID: 19859659	2010
GammaH2AX as a molecular marker of aging and disease. Epigenetics : official journal of the DNA Methylation Society\| PubMed ID: 20150765	2010
Methylproamine protects against ionizing radiation by preventing DNA double-strand breaks. Mutation research\| PubMed ID: 20732333	2010
Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. Aging\| PubMed ID: 20930262	2010
Protection by methylproamine of irradiated human keratinocytes correlates with reduction of DNA damage. International journal of radiation biology\| PubMed ID: 21087168	2011
Genetic and epigenetic events in diabetic wound healing. International wound journal\| PubMed ID: 21159125	2011
Epigenome targeting by probiotic metabolites. Gut pathogens\| PubMed ID: 21172038	2010
Double-strand breaks and the concept of short- and long-term epigenetic memory. Chromosoma\| PubMed ID: 21174214	2011
Evaluation of the efficacy of radiation-modifying compounds using Î³H2AX as a molecular marker of DNA double-strand breaks. Genome integrity\| PubMed ID: 21261999	2011
Effects of oral intake of water in patients with oropharyngeal dysphagia. BMC geriatrics\| PubMed ID: 21356121	2011
Photosensitization by iodinated DNA minor groove binding ligands: Evaluation of DNA double-strand break induction and repair. Journal of photochemistry and photobiology. B, Biology\| PubMed ID: 21440453	2011
Molecular model of naphthalene-induced DNA damage in the murine lung. Human & experimental toxicology\| PubMed ID: 21508073	2012
Histone deacetylase inhibitors augment doxorubicin-induced DNA damage in cardiomyocytes. Cellular and molecular life sciences : CMLS\| PubMed ID: 21584806	2011
Chromatin modifying agents - the cutting edge of anticancer therapy. Drug discovery today\| PubMed ID: 21664485	2011
Investigation into the biological properties of the olive polyphenol, hydroxytyrosol: mechanistic insights by genome-wide mRNA-Seq analysis. Genes & nutrition\| PubMed ID: 21953375	2011
Potential non-oncological applications of histone deacetylase inhibitors. American journal of translational research\| PubMed ID: 22046487	2011
Protective effects of valproic acid against airway hyperresponsiveness and airway remodeling in a mouse model of allergic airways disease. Epigenetics : official journal of the DNA Methylation Society\| PubMed ID: 22139576	2011
Utility of Î³H2AX as a Molecular Marker of DNA Double-Strand Breaks in Nuclear Medicine: Applications to Radionuclide Therapy Employing Auger Electron-Emitting Isotopes. Current radiopharmaceuticals\| PubMed ID: 22191615	2011
Influence of Natural and Synthetic Histone Deacetylase Inhibitors on Chromatin. Antioxidants & redox signaling\| PubMed ID: 22229817	2012
Histone deacetylases and their role in asthma. The Journal of asthma : official journal of the Association for the Care of Asthma\| PubMed ID: 22233225	2012